EMVision Medical Devices Ltd (ASX:EMV) Announces Quarterly Update
EMVision Medical Devices Ltd reports advancements in validation trials and strong financial positioning in its quarterly update.

EMVision Medical Devices Ltd reports advancements in validation trials and strong financial positioning in its quarterly update.
EBR Systems (ASX:EBR) announces the lease of a new facility to enhance its manufacturing capabilities for future growth.
Terramin Australia Ltd (ASX:TZN) reports key milestones in project advancements, legal developments, and financial performance in its December 2024 quarterly report.
Dimerix Limited (ASX:DXB) announces licensing agreement in Japan and significant progress in its Phase 3 clinical trial in the latest quarterly report.
BrainChip Holdings Ltd reports a US$20M cash balance and successful contract wins for neuromorphic AI technology.
ECS Botanics reports significant growth in B2C sales and strong operational performance for Q2 FY25.
Sprintex Limited (ASX:SIX) reports significant sales commitments and operational gains for the December quarter, reinforcing growth prospects.
Singular Health Group (ASX: SHG) reports key partnerships, equity raise success, and a solid cash position as of December 31, 2024.
Sigma Healthcare reports Chemist Warehouse Group’s record sales and margin growth for 1H FY25 amid robust trading performance.
IDT Australia Limited (ASX:IDT) reports an 82% revenue increase, primarily driven by growth in the Advanced Therapies business segment.